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Abstract
During respiratory syncytial virus (RSV) infection there is a close physical interaction between the filamentous actin (F-actin) and the virus,
involving both inclusion bodies and the virus filaments. This interaction appears to occur relatively early in the replication cycle, and can be
detected from 8 h post-infection. Furthermore, during virus assembly we obtained evidence for the participation of an F-actin-associated signalling
pathway involving phosphatidyl-3-kinase (PI3K). Treatment with the PI3K inhibitor LY294002 prevented the formation of virus filaments,
although no effect was observed either on virus protein expression, or on trafficking of the virus glycoproteins to the cell surface. Inhibition of the
activity of Rac GTPase, a down-stream effector of PI3K, by treatment with the Rac-specific inhibitor NSC23766 gave similar results. These data
suggest that an intimate interaction occurs between actin and RSV, and that actin-associated signalling pathway, involving PI3K and Rac GTPase,
may play an important role during virus assembly.
© 2007 Elsevier Inc. All rights reserved.Keywords: Respiratory syncytial virus; Virus assembly; F-actin; Phosphatidyl-3-kinase; Rac GTPaseIntroduction
Respiratory syncytial virus (RSV) is the major cause of
severe lower respiratory tract disease in several high-risk groups
which include young children, the elderly and immunocom-
promised adults. The mature, infectious virus particle comprises
a ribonucleoprotein (RNP) core that is formed by the interaction
of the viral genomic RNAwith the nucleocapsid (N) protein, the
phosphoprotein (P) and the large (L) protein. The M2-1 protein
is an additional virus protein that is required for efficient
transcription of the virus genome by the polymerase complex
(Grosfeld et al., 1995; Yu et al., 1995; Collins et al., 1996;
Hardy and Wertz, 1998; Fearns and Collins, 1999). In mature⁎ Corresponding author. School of Biological Sciences, NTU, 60 Nanyang
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doi:10.1016/j.virol.2007.08.007virus particles, the RNP is surrounded by two layers, the matrix
(M) protein and a lipid envelope derived from the host cell.
Three virus-encoded glycoproteins, the attachment (G), fusion
(F) and small hydrophobic (SH) proteins are embedded within
this envelope. The virus exhibits a pleomorphic morphology
which ranges from largely spherical to filamentous in shape.
Although the precise relationship between these different virus
forms is currently unclear, these different morphological forms
of the virus are infectious.
Although the basic structural organisation of the mature RSV
particle is well characterised (Norrby et al., 1970; Bachi and
Howe, 1973; Parry et al., 1979; Roberts et al., 1995; Arslanagic
et al., 1996; Brown et al., 2002a), the virus assembly process is
still relatively poorly understood. Studies using both light and
electron microscopy have shown that RSV matures predomi-
nantly as filamentous structures on the surface of infected cells.
These structures are largely responsible for the cell-to-cell
310 C.E. Jeffree et al. / Virology 369 (2007) 309–323transmission of the virus, which in tissue culture is manifested
by syncytial formation. Lipid-rafts have been implicated in the
assembly process (Brown et al., 2002a,b; Jeffree et al., 2003;
McCurdy and Graham, 2003; Brown et al., 2004) and an
accumulation of experimental evidence suggests that elements
of the cytoskeleton also play an important role during virus
morphogenesis (Burke et al., 1998; Ulloa et al., 1998;
Kallewaard et al., 2005; Santangelo and Bao, 2007).
Avariety of different signalling pathways are associated with
the cytoskeleton, which include those mediated by Rho
GTPases. Previous studies have shown that Rho A is activated
during RSV infection, and inhibiting the activation of RhoA has
a deleterious affect on virus assembly (Gower et al., 2001, 2005).
This has suggested a role for RhoA in the formation of virus
filaments, although the mechanisms involved have not been
defined. The high-resolution imaging data presented here
provide evidence for a direct interaction between the F-actin
network and virus filaments, although the process of active actin
polymerisation was not required for virus filament formation. In
addition, by inhibiting the activity of the actin-associated lipid
kinase PI3K, and its down stream effector Rac GTPase, the
formation of virus filaments was impaired, suggesting a role for a
PI3K-dependent signalling pathway in the virus assembly
process. Recent evidence has suggested that PI3K plays a role
during the latter stages of the RSV replication cycle by
preventing apoptosis (Thomas et al., 2002; Bitko et al., 2007).
However, our experimental data provide evidence for a direct
interaction between actin and mature RSV, and suggests that
PI3K signalling may play an additional role during virus
infection that is related to the formation ofmature virus filaments.
Results and discussion
Ultrastructural evidence for a direct interaction between
virus-induced structures and the cytoskeleton network
The RSV maturation process has been examined previously
using field emission scanning electron microscopy (FE SEM)
(Jeffree et al., 2003). However, in these earlier studies, the cells
were carbon-coated to prevent charging of the cell monolayer in
the SEM. Although this is a standard procedure, the coating
thickness is difficult to control (approximately 20 nm thick-
ness), and this prevents a detailed appreciation of the surface
topography of the maturing virus. Our existing protocols have
been modified by coating the cells with sputtered chromium
(Cr), which allows the controlled application of a much thinner
layer. A coating thickness of 2 nm appeared to be optimal, as it
allowed visualisation of surface detail and produced minimal
“charging” of the sample at high magnification. However, at
high magnification, a small degree of “charging” of the glass
substrate was observed with the thinner Cr coating. This was
prevented by the use of silicon as a cell substrate, since silicon is
a much better conductor than glass. Prior analysis by SEM
showed that both virus and cell morphology on glass and silicon
substrates were indistinguishable (unpublished observations),
suggesting that the use of silicon has no effect either on cell
growth or the formation of virus.Examination of virus-infected cells at low magnification,
using the secondary electron (SE) detector, revealed many virus
filaments on the cell surface (Fig. 1, plate A), which were
similar in appearance to those seen previously (Parry et al.,
1979; Roberts et al., 1995; Brown et al., 2004). In addition, the
virus filaments had a tapered appearance (Fig. 1, plate B) which
was not obvious in our earlier studies employing FE SEM
(Jeffree et al., 2003), presumably due to the application of
relatively thick carbon and gold coatings on the cells. At their
narrowest the filaments were approximately 90 nm in diameter,
while at their broadest part they were approximately 150 nm in
diameter (Fig. 1, plate B, highlighted by ⋄), however the
physiological significance of this tapering effect is unclear. In
mock-infected cells these filaments were absent, but much
smaller finger-like projections were present, whose appearance
was consistent with that of the microvilli (Brown et al., 2004).
Previous high magnification examination by SEM of carbon-
coated RSV-infected cells had revealed protrusions on the
surface of the virus filaments (Jeffree et al., 2003). However, the
surface topology of the virus filaments would have been masked
by the relatively thick carbon coating used. In contrast,
examination of the Cr-coated samples at high magnification
allowed detailed examination of the surface topography of the
virus filaments at various locations along their lengths. This
examination revealed that the surface of the virus filaments
appeared to be organised into distinct compartments that are
between 20 and 30 nm in diameter, giving rise to a mosaic-like
appearance over their surface (Fig. 1, plate C). A closer
examination of these compartments revealed that they were
composed of numerous “pinhead-like” structures (Fig. 1, plate
C inset). Although these structures showed a size variation, they
appeared to be approximately 5 nm or less in diameter, possibly
representing the locations of protein clusters on the surface of
the virus filaments. The dimensions of these structures are
consistent with those reported for many virus glycoproteins,
including the RSV F protein (Calder et al., 2000). The virus
origin of the filaments was confirmed by immunolabelling
virus-infected cells with MAb30, an antibody which binds to
the RSV G protein, and visualising the cells using the back-
scatter electron (BSE) detector (Jeffree et al., 2003). Bound
antibody was detected with the secondary antibody conjugated
to 10 nm colloidal gold, and gold particles were visible in the
BSE detector as white spots (Fig. 1, plate D, highlighted by
white arrow).
To obtain a better understanding of how the virus interacts
with the cell membrane during virus morphogenesis, it is
necessary to examine the processes that occur beneath the cell
membrane. Of particular interest is the interaction between the
cytoskeleton and the maturing virus particles, since recent
biochemical evidence has suggested a role for the cytoskeleton
during virus assembly, and the subsequent release of RSV
particles from infected cells (Kallewaard et al., 2005). Poly-
merised actin, polymerised tubulin, and intermediate filaments
form the three major components of the cytoskeleton network.
Filamentous actin (F-actin) forms a relatively flexible structure
consisting of fibres that have a diameter of approximately 6 nm.
Although it forms an extensive network of filaments throughout
Fig. 1. Visualisation of virus filaments by FE SEM. RSV-infected cells were labelled with MAb30 and the bound antibody was detected using 10 nm colloidal gold.
The samples were processed for SEM and coated with a 2 nm thickness of chromium (Cr). The monolayer surface was viewed using the secondary electron (SE) (plates
A, B and C) and back scatter electron (BSE) (plate D) detectors which allow visualisation of virus morphology and the presence of colloidal gold, respectively. The
virus filaments are also indicated (VF). Plate A, low magnification image (×3000) of virus filaments on the surface of infected cells. Plate B, higher magnification
image (×25,000) of the virus filaments which reveals that they are not of uniform thickness, but generally appear to have a broader base (highlighted by ♢). Plate C,
higher magnification (×110,000) shows the mosaic appearance of the RSVenvelope. Further magnification (plate C inset) reveals that within this mosaic pattern are
numerous pinhead-like structures, some of which are highlighted by white arrowheads. Plate D, analysis of virus filaments at high magnification (×110,000) using the
BSE detector. Gold particles on the virus filaments are visualised as small bright points (highlighted by white arrows). This shows the distribution of colloidal gold-
labelling due to the boundMAb30 within the envelope of the virus filaments. The small bright points correspond to the larger projections (⁎) on the virus filaments that
are viewed using the SE detector (plate C), which represent the location of the bound antibody. The scale bar on each image is indicated.
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membrane, providing structural support for cell-surface features
e.g. microvilli. Microtubules are long, hollow, rigid filaments,
approximately 25 nm in diameter, constructed from poly-
merised chains of tubulin. Intermediate filaments form fibres
approximately 10 nm in diameter which span the cell
cytoplasm, and are formed from a diverse group of proteins,
e.g. vimentin and desmin. The structure formed by F-actin can
be distinguished morphologically from the other structural
elements that form the cytoskeleton network by electron
microscopy (Fawcett, 1981).
To aid our understanding of the role played by the
cytoskeleton network during virus assembly, high-resolution
imaging of virus-infected cells was performed to determine the
relative distributions of the cytoskeleton and virus filaments. A
major limitation of standard FE SEM is the inability to visualise
features which are present beneath the plasma membrane of the
cell. Therefore, mock- and virus-infected cells were detergent-
extracted using Triton-X100 in the presence of phalloidin and
taxol, which stabilise the F-actin and microtubule networks
respectively. This process removes the cell membrane, but the
underlying cytoskeleton network is retained, together with thevirus filaments. Initially we performed this procedure at 4 °C,
and we obtained good extraction of the cells, and the cell
cytoskeleton and virus filaments were visible (Fig. 2, plate A).
However, when examined at high magnification we noted that
the virus envelope was retained on the virus filaments, which
obscured the visualisation of their interaction with the
cytoskeleton (Fig. 2, plate B). The retention of the virus
envelope is presumably a consequence of the virus forming
from lipid-raft membranes. We therefore adopted an alternative
procedure based on the method of Schliwa et al. (1981). In this
case extraction of the cell membrane was performed using a
slightly lower Triton-X100 concentration, but the procedure is
carried out at 25 °C.
In mock-infected cells, the cytoskeleton was visible as a thin
fibrous network, extending across the cell (Fig. 2, plates C and E).
In addition, structures resembling virus filaments were observed
in the infected cells (Fig. 2, plates D and F). These structures
were approximately 90 nm wide and were easily distinguishable
from the relatively much thinner cytoskeleton network. A
significant reduction in the width of the virus filaments was
observed following detergent-extraction of the cells, which is
due presumably to the removal of the virus envelope, together
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magnification provided evidence for a direct interaction between
the virus filaments and the cytoskeleton network during virus
assembly (Fig. 2, plate G, highlighted by white arrow). In
addition, we noted in some infected cells the appearance ofstructures that had formed beneath both the cytoskeleton and the
virus filaments (Fig. 2, plate G, highlighted by ⁎). Although their
significance is currently unclear, they may represent the
accumulation of virus proteins in the cell, e.g. the presence of
inclusion bodies.
Fig. 3. The virus filaments interact with F-actin at the cell surface. Plates A and B, RSV-infected cells were labelled with MAb30 (recognises the G protein) and stained
with phalloidin-FITC to detect the F-actin distribution. Selected images from the same cells at different optical planes that correspond to the cell interior (plate A) and
cell surface (plate B) are shown. Plate C, infected cells were labelled using anti-F and anti-tubulin and the distribution of the microtubule network and virus filaments
visualised respectively, in an optical plane similar to that observed in plate B. The presence of actin-stress fibres (⁎), the microtubule network (M) and virus filaments
(VF) are highlighted. Colocalisation is indicated by the yellow staining pattern. Plate D, the formation of virus filaments is not dependent upon actin polymerisation.
Cells were infected with RSV and at 5 h pi the cells were treated with cytochalasin D (CYTD). At 20 h pi, the cells were stained with phalloidin-FITC (green) and
labelled with MAb30 (red). A selected image at an optical plane that represents the cell surface is shown. The colocalisation between the different reagents are
highlighted (⁎) in the merged image.
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extracted cells was confirmed by immunolabelling the cells
with anti-RSV (Fig. 2, plates H and I), a composite antibody
preparation that recognises the F, N and P proteins (Wright et
al., 1997). However, under the fixation conditions used, only
the antigenicity of the RNP-associated proteins is retained
(McDonald et al., 2006). Although the virus filaments are
labelled with this antibody (Fig. 2, plate I, highlighted by white
arrow), some sporadic labelling of the cytoskeleton was also
observed (Fig. 2, plate I, highlighted by ⁎), the significance of
which is currently unclear, but may indicate cytoskeleton-
associated N and P protein. This is consistent with previous
reports that have employed molecular techniques to examine
interactions between actin and the RSV polymerase complex
(Barik, 1992; Burke et al., 1998).
RSV-infected cells were analysed by fluorescence micro-
scopy in an attempt to determine which elements of the cyto-Fig. 2. In situ distribution of the cytoskeleton network and virus filaments revea
highlighted. Virus-infected cells were extracted with 1% Triton-X100 and the cells
between the virus filaments and cytoskeleton is highlighted (white arrow); however th
procedure the cytoskeletons were prepared in situ from mock- and RSV-infected cell
detector and recorded either at ×3,000 (plates C and D) or ×55,000 (plates E an
ultrastructural evidence for a direct interaction between the cytoskeleton network and
is also highlighted. Plates H and I, immunolabelling of the virus filaments within the in
cells and labelled with anti-RSV. The location of the bound antibody was detected usin
location were recorded using the SE (plate H) and BSE (plate I) detectors respectively
visualised as small bright points (highlighted by white arrow). Some sporadic labellskeleton were associated with the maturing virus particles. The
presence of virus filaments was detected with MAb30, an
antibody raised against the G protein. The F-actin network was
visualised using phalloidin-FITC, which binds to F-actin. RSV-
infected cells were labelled with MAb30 (red) and stained with
phalloidin-FITC (green) (Fig. 3, plates A and B) and a series of
images at different focal planes were obtained from the same
cell that correspond to the cell interior (Fig. 3, plate A), and the
optical plane corresponding to the cell surface (Fig. 3, plate B)
in which a proportion of the virus filaments can be seen. In the
cell interior, F-actin exhibited a green filamentous staining
pattern (Fig. 3, plate A, highlighted by ⁎) and some G protein
labelling (red) was also observed. However, there was no
significant colocalisation between F-actin and the G protein. In
contrast, a high degree of colocalisation between F-actin and the
G protein was observed at the cell surface (Fig. 3, plate B,
yellow colour), but this co-localisation was not observed withinled by FE SEM. The virus filaments (VF) and cytoskeleton network (C) are
examined at either ×6000 (plate A) or ×90,000 (plate B). The point of contact
is interaction is obscured by the presence of the virus envelope. In an alternative
s by removal of all the lipid membrane. The images were obtained using the SE
d F) magnification. Plate G, a high magnification image (×90,000) provides
virus filaments (highlighted by white arrow). Material below the cytoskeleton (⁎)
situ cytoskeleton preparations. Cytoskeletons were prepared from RSV-infected
g a second antibody conjugated to 10 nm colloidal gold. Images for the same cell
at ×35,000 magnification. The presence of gold particles on the virus filaments is
ing of the cytoskeleton network is also highlighted (⁎).
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infected cells were stained using antibodies that recognise other
virus proteins, such as the F, N and P (Brown and Sugrue,
unpublished observations). However, the direct interaction
between the virus filaments and the F-actin network during
virus assembly supports the proposal that actin may play an
important role in the virus assembly process. In addition, the
actin stress fibres, clearly visible in the cell, appeared to have no
interaction with the virus filaments. This suggests that the
interaction between the virus filaments and actin may involve
the cortical F-actin network, which is located directly under the
plasma membrane. In a similar analysis, virus-infected cells
were labelled with anti-tubulin to visualise the microtubule
distribution and no colocalisation was observed between these
cellular structures and the virus filaments (Fig. 3, plate C).
Similarly, no significant colocalisation was observed when the
intermediate filament network was examined during virus
infection (Brown and Sugrue, unpublished observations).
Although this does not rule out the involvement of the micro-
tubule or intermediate filament networks in virus assembly, our
results suggest a direct role only for the actin network.
The results obtained using light and electron microscopy
suggested a role for F-actin in the assembly of RSV particles.
This possibility was examined further by investigating the effect
of inhibitors of actin polymerisation on virus assembly. The
results obtained with one such inhibitor, cytochalasin D
(CYTD), are described. This inhibitor binds to the ends of
F-actin filaments, preventing the addition of new G-actin
monomers to the actin filaments. RSV-infected cells were
treated with CYTD at 5 h post-infection (pi), and at 20 h pi the
cells were labelled with MAb30 and stained with phalloidin-
FITC (Fig. 3, plate D). As expected, in the presence of CYTD
the F-actin stress fibres were not detected and the F-actin
exhibited a punctate staining pattern on the cell surface. In
addition, virus filaments were observed on the CYTD-treated
cells (Fig. 3, plate D, highlighted by VF). However, although
the F-actin distribution changed to a punctate staining pattern,
there was still a significant level of colocalisation between these
residual F-actin structures and the G protein (Fig. 3, plate D,
highlighted by ⁎). This suggests that although there appears to
be an interaction between the virus filaments and F-actin, new
actin polymerisation was not a prerequisite for the formation of
the virus filaments. In addition, the presence of actin-stress
fibres was also not a prerequisite for virus filament formation,
which agrees with recent findings (Bitko et al., 2003). It is not
clear if the F-actin structures that were stained by phalloidin-
FITC in the presence of CTYD represent some preformed
F-actin structure, to which the virus proteins are targeted.
Although the virus filaments were observed on both the non-
treated and CYTD-treated cells, the limited resolution offered
by light microscopy was unable to provide detailed information
on the effect of CYTD treatment on virus assembly. The surface
of non-treated and CYTD-treated virus-infected cells was
therefore examined by FE SEM, to determine if inhibiting
actin polymerisation had any effect on virus filament formation.
RSV-infected cells were either non-treated or CYTD-treated,
and then labelled with MAb30 to detect the G protein asdescribed above (Fig. 4). This allowed a comparison of both the
morphology of the virus filaments, and the levels of G protein
within the virus envelope. In the absence of CYTD, the cells
exhibited their normal morphology (Fig. 4, plate A), whereas in
the presence of CYTD the cell morphology changed in
appearance (Fig. 4, plate B). This is consistent with the cell
shape changes that arise due to destabilisation of the F-actin
network. However, virus structures on the cell surface that
resembled virus filaments were also detected in CYTD-treated
cells (Fig. 4, plate B), confirming that CYTD treatment did not
prevent formation of the filaments. In addition, comparable
levels of G protein-labelling were seen within the virus
filaments of both non-treated and treated cells (Fig. 4, plates
C and D).
Recent studies have shown that CYTD-treatment of virus-
infected cells can reduce the levels of virus that are released
from the cell during the replication cycle (Kallewaard et al.,
2005). Therefore, in a parallel analysis, the virus protein
content of RSV particles produced in the presence and absence
of CYTD was assayed by radio-immunoprecipitation (RIP) to
determine if drug treatment had any effect on the recruitment of
the internal virus structural proteins to the site of virus
assembly. Non-treated and CYTD-treated cells were radiola-
belled with [35S]methionine and the total virus (both cell-
associated and cell free) was isolated from the infected cells by
centrifugation (McDonald et al., 2006), prior to detergent-
extraction and analysis by RIP using either anti-RSVor anti-M
(Henderson et al., 2002). Analysis of the respective RIP
reactions by SDS PAGE revealed virus proteins of the expected
sizes (Fig. 4, plate E). Furthermore, the relative proportions of
the immunoprecipitated proteins remained unchanged follow-
ing CYTD treatment. As expected, these proteins were not
detected in the samples from mock-infected cells prepared in an
identical manner.
Collectively these data suggest that although F-actin interacts
with the virus filaments, the formation of newly polymerised
actin is not required, either for the recruitment of virus proteins to
the sites of virus assembly, or for the subsequent formation of
virus filaments. Our data also suggest that the presence of
preformed and stable actin structures at the cell surface may be
important for the process of virus assembly. However, previous
studies suggest that these locations are unlikely to represent the
sites of microvilli formation (Brown et al., 2004).
The association of F-actin with virus inclusion bodies
In addition to virus filaments, during virus infection
inclusion bodies are also produced within the cytoplasm of
infected cells. They can be detected as early as 8 h pi, being
clearly visible by 24 h pi (Fig. 5, plates A), and their appearance
correlates with the expression of inclusion body-associated
virus proteins e.g. M2-1 (Fig. 5, plate B). These structures
represent sites in the cell where the polymerase-associated
proteins accumulate during infection. Furthermore, the presence
of clusters of vRNAwithin the cytoplasm of RSV-infected cells
whose appearance resemble inclusion bodies has recently been
reported (Santangelo et al., 2006). Although the formation of
Fig. 4. Analysis of the virus protein composition within mature RSV following CYTD-treatment. Mock-treated (plates A and C) and CYTD-treated (plates B and D)
RSV-infected cells were incubated with MAb30, and the bound antibody was detected using 10-nm colloidal gold as described in Methods. Plates A and B, the surface
of the cell monolayers was visualised using the SE at low magnification. Plates C and D, distribution of the G protein was examined at higher magnification using the
BSE detector. Gold particles in the BSE images are seen as small bright points (highlighted by white arrow). Also visible is a small amount of background signal due to
osmium tetroxide staining which allows the outline of the virus filaments to be seen. Plate E, analysis of the protein content of RSV particles formed in the absence and
presence of CYTD. [35S]methionine-labelled virus particles were prepared from mock-treated (−) or CYTD-treated (+) virus-infected (I) cells as described in Methods.
The cell free virus was harvested, detergent-extracted, immunoprecipitated using either anti-M protein or anti-RSV, and the immunoprecipitates analysed by SDS
PAGE. The positions of the various proteins are indicated. A RIP analysis using cell-free material obtained from mock-infected (M) cells is also shown.
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they play during virus infection is currently unclear. These
structures have been shown to form in the absence of virus
infection, by recombinant expression of the polymerase-
associated proteins in mammalian cells (Garcia et al., 1993),
suggesting that the formation of inclusion bodies may be an
intrinsic property of these proteins. Recent evidence has also
suggested that other cellular structures associate with the
inclusion bodies, including cellular membranes and elements of
the cytoskeleton (Brown et al., 2005). Since they represent sites
of accumulation of internal virus proteins that are presumably
destined for incorporation into progeny virus, we analysed their
cellular distribution in more detail.
Virus-infected cells stained using anti-N and examined by
confocal microscopy revealed that in each cell several cyto-
plasmic inclusion bodies were present (Fig. 5, plate C, high-lighted by white arrow). Furthermore, analysis of infected cells
in cross-section (Fig. 5, plate C, a,b) suggested that although
most of the inclusion body was present with the cell interior,
they appeared to be close proximity, and in some cases direct
contact, with the cell surface. This suggested a direct interaction
with the virus filaments that form above the inclusion bodies.
Evidence for a direct association of the virus filaments and
inclusion bodies can be seen when infected cells are viewed by
TEM (Fig. 5, plate D). It should be noted that this is a frequent
observation in our TEM analysis. However, we also noted
filaments on the cell surface (shown by cell surface staining in
Fig. 5, plate C, a,b), which appeared to be distant from the
inclusion body. This suggested that if direct transfer of virus
components from the inclusion bodies to the virus filaments
occurs, this may involve cellular structures (e.g. the cytoske-
leton), and this possibility was investigated further.
Fig. 5. The distribution of inclusion bodies within virus-infected cells. Plates A and B, the formation of inclusion bodies occurs early in the virus replication cycle.
HEp-2 cells were infected with RSV, and at various times post-infection the cells were either (plate A) fixed, stained using anti-M2-1 and examined by confocal
microscopy or (plate B) the cells harvested and the presence of the M2-1 protein detected by western blotting using anti-M2-1. The inclusion bodies in the cell are
highlighted (white arrow). Plate C, examination of inclusion bodies within infected cells. Infected cells were stained with anti-N and a series of images obtained from
the same cell in the Z-axis. These images were then analysed using LSM510 software. The distribution of three individual inclusion bodies can be seen (highlighted by
white arrow) when viewed in the cross-sectional images (a and b). Plate D. The association between virus filaments (VF) and inclusion body (IB) is revealed by
immuno-electron microscopy. RSV-infected cells were immunolabelled using anti-RSVand the presence of bound antibody is visualised using a secondary antibody
conjugated to 10 nm colloidal gold particles (black spots, highlighted by black arrows).
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described in methods. Virus-infected cells were either fixed
with glutaraldehyde, osmium tetroxide and tannic acid (the
latter reagents stabilise protein and lipid) and embedded using
Epon812, or fixed with glutaraldehyde and embedded in
Unicryl as described previously (Brown et al., 2002a,b). Tannic
acid staining also causes cell membranes to become more
clearly delineated, thus allowing better visualisation of
membrane structures in virus-infected cells (Fig. 6, plate A).
In this analysis, the inclusion bodies were visualised as distinct
structures, being similar in appearance to those describedpreviously. Thin sections taken from virus-infected cells were
also immunolabelled using anti-RSV, and the presence of bound
antibody detected using secondary antibody conjugated to
10 nm colloidal gold (Fig. 6, plate B), confirming their virus
origin. As expected, these structures were not present in mock-
infected cells (Aitken and Sugrue, unpublished observations).
We also observed that inclusion bodies were not amorphous
structures but contained large vacuoles of varying sizes within
their interior (Fig. 6, plates A and B). Furthermore, a closer
inspection of the periphery of the inclusion bodies suggested the
presence of a membrane-like structure (Fig. 6, plate A inset a).
Fig. 6. The association of inclusion bodies with lipid membrane structures is revealed by high-resolution transmission electron microscopy. Plates A and B, analysis of
the inclusion bodies also reveals the presence of membrane-bound structures (white arrow heads), internal membrane-bound vacuoles (⁎), and the inclusion body-
associated vesicles (V). Plate A inset a, the presence of a membrane–like layer over the inclusion body is highlighted (by white arrow). Plate A inset b, high
magnification image showing the presence of smaller spherical membrane-like structures (highlighted by black arrows) within the inclusion body-associated vesicles.
Plate B, RSV-infected cells were immunolabelled using anti-RSVas described in Methods. The presence of bound antibody is visualised using a secondary antibody
conjugated to 10 nm colloidal gold particles (black spots, highlighted by white arrows).
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that were physically associated with the exterior of the inclusion
bodies. These vesicles were not empty, but appeared to contain
numerous smaller structures that appeared to be bound by
membrane (Fig. 6, plate A inset b). So far, we have failed to
determine if these structures are of virus origin, since they could
not be efficiently labelled with the range of RSV-specific
immunological reagents that were available to us. However,
these data support recent evidence that inclusion bodies are
associated with lipid structures (Brown et al., 2005).
Visualisation of elements of the cell cytoskeleton was
considerably enhanced in our analysis, which allowed us to
view the spatial relationship between the inclusion bodies and
the cytoskeleton by electron microscopy (Fig. 7). A detailed
analysis of the virus inclusion bodies showed the appearance of
filamentous structures resembling actin which appeared to
radiate away from these structures towards the cell surface (Fig.
7, plates A and B). In addition, we noted that material appeared
to associate with these filamentous structures that labelled with
anti-RSV (Fig. 7, plate B, highlighted by black arrow). This
association of virus proteins with elements of the cytoskeleton,
and in some cases their close proximity to virus filaments (Fig.
5, plate D), lends support to the notion that the cytoskeleton
could act as a conduit for the transport of internal proteins from
the inclusion bodies to the sites of virus assembly at the plasma
membrane. Although this suggestion is supported by recent data
suggesting a role for the cytoskeleton in virus assembly
(Santangelo and Bao, 2007), it requires further investigation
and remains to be established.
In previous studies we noted that actin appeared to be
associated with the inclusion bodies (Brown et al., 2005),
although our analysis was limited by the resolution of lightmicroscopy. However, it did suggest an association between
these two structures. We therefore improved this analysis by
examining the distribution of actin and the inclusion bodies
using TEM. Virus-infected cells were embedded in uniacryl and
thin sections labelled using anti-actin, and the presence of
bound antibody detected using secondary antibody conjugated
to 10 nm colloidal gold (Fig. 7, plates C and D). Unlike
phalloidin-FITC, anti-actin recognizes both F-actin and the
monomeric form of actin, called globular (G)-actin. This
analysis revealed labelling of filamentous structures in the
cytoplasm whose appearance was consistent with F-actin,
together with labeling of structures whose morphology was
consistent with inclusion bodies. In addition, we noted that the
antibody appeared to label some of the virus filaments (Fig. 7,
plate C) suggesting that actin may be present within these
structures. The inability to detect the presence of F-actin within
the virus filaments suggests that this may represent G-actin.
This is consistent with our previous TEM studies which failed
to detect any structures resembling F-actin (or any other
cytoskeleton elements) within virus particles (Brown et al.,
2002a).
The involvement of actin-associated lipid kinases in virus
filament formation
We have noted that in HEp-2 cells virus filaments start to
form at approximately 10 h pi and that by 15 h pi they are
clearly visible on the cell surface (Brown and Sugrue,
unpublished observations). Furthermore, their appearance
correlates with changes in the expression profile of genes
encoding specific actin-associated proteins, and we also noted
increases in transcriptional levels of two lipid kinases,
Fig. 7. The association of inclusion bodies with actin is revealed by high-
resolution transmission electron microscopy. Thin sections were prepared from
RSV-infected cells and labelled using either anti-RSV (plates A and B) or anti-
actin (plates C and D) and the presence of bound antibody visualised using a
secondary antibody conjugated to 10 nm colloidal gold particles (black spots,
highlighted by black arrows). The presence of virus filaments (VF), inclusion
bodies (IB) and cytoskeleton elements that resemble F-actin (C) are also
highlighted.
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phosphatidylinositide-3-kinase (PI3K) (Yeo, Tan and Sugrue,
unpublished observations). These lipid kinases have beenimplicated in a variety of cellular processes, including actin
remodelling. RhoA induces the activity of signalling pathways
that involve PIPK1 and PI3K (Chong et al., 1994; Oude
Weernink et al., 2000; Santarius et al., 2006) and PI3K is able
to regulate the activities of several proteins that contain
pleckstrin homology (PH) domains, including proteins that
can modulate actin structure. During this process, phosphoino-
sitides are sequentially phosphorylated by PIPK1 and PI3K, by
the addition of one, two and three phosphate groups yielding
phosphoinositide-4-phosphate (PI4P), phosphoinositide (3,4)
phosphate (PI(4,5)2) and phosphoinositide (3,4,5) phosphate
(PIP3) respectively. PI4P is the substrate for PIPK1, and the
product of this reaction (PI(4,5)2) is the substrate for PI3K,
which then yields PIP3. PIP3 binds to several different effector
proteins containing PH domains, an event which is then able to
trigger several specific signalling pathways depending on the
effector protein that is involved (reviewed in Hawkins et al.,
2006; Engelman et al., 2006). For example, PIP3 has the ability
to bind to Rac guanidine exchange factors (GEF) (Innocenti et
al., 2003) which are then able to activate several other proteins,
such as Tiam, which are involved in cytoskeleton organisation.
Furthermore, recent evidence has demonstrated that down-
stream effectors of PI3K, such as Akt, can bind actin and actin-
binding proteins such as α-actinin (Vandermoere et al., 2007).
This highlights the close association between F-actin and
specific signalling pathways, such as those involving PI3K.
Recent reports have suggested that PI3K is activated during
virus infection, and a role for activated PI3K in regulating the
cellular pathways that initiate apoptosis during RSV infection
has been demonstrated (Thomas et al., 2002; Bitko et al., 2007).
These authors showed that an increase in PI3K activity occurred
relatively early in the infection process (30 min post-infection),
suggesting to us that PI3K could also play an additional role
during the early phase of the virus replication cycle. We
therefore examined the effect of PI3K activity on virus
morphogenesis during the early stages of virus infection. In
this study, the effect of PI3K activity on the formation of virus
filaments and inclusion bodies was examined using the drug
LY294002, which is a well characterised and specific inhibitor
of PI3K activity (Vlahos et al., 1994). Virus-infected cells were
either non-treated, or treated with 50 μM LY294002 at 6 h pi,
and at 15 h pi the cells were analysed by fluorescence
microscopy. Non-treated and LY294002-treated cells were
labelled either with MAb19 or with anti-RSV (Fig. 8, plates
A–D), and the bound antibody was detected using a second
antibody conjugated to FITC. MAb19 allows the detection of
the virus filaments on the cell surface, while anti-RSV allows
the detection of inclusion bodies. As expected, in non-treated
cells we observed the presence of many relatively long virus
filaments distributed over the entire cell surface (Fig. 8, plate A
inset). In contrast, MAb19-labelled LY294002-treated cells
revealed a speckled staining pattern, and had lost this prominent
filamentous staining pattern (Fig. 8, plate C inset, highlighted
by ⁎). However, both treated and non-treated cells appeared to
show similar levels of antibody labelling, suggesting that drug
treatment did not impair targeting of the F protein to the cell
surface. This conclusion was supported by measuring the levels
Fig. 8. Phosphatidylinositol 3-kinase (PI3K) signalling activity is required for efficient virus filament formation. Virus-infected cells were either (NT) non-treated
(plates A and B), treated with LY294002 (plates C and D) or treated with NSC23766 (plates E and F) for between 6 and 15 h pi. The cells were then processed and
labelled either with MAb19 (plates A, C and E) or anti-RSV (plates B, D and F). The virus filaments (VF) and inclusion bodies (IB) are highlighted. Plate A inset, the
filamentous staining pattern in non-treated cells is highlighted (white arrow). Plates C and E insets, the speckled labelling pattern that arises when drug-treated cells are
labelled using MAb19 is highlighted (⁎). Plates G and H, treatment with LY294002 does not prevent targeting of the virus glycoproteins to the cell surface. Plate G,
infected cells were either treated with LY294002 (I+LY294002) or left untreated (I) and the cell surface proteins biotinylated as described previously (Sugrue et al.,
2001). The F protein was isolated by immunopreciptation using MAb19, separated by SDS PAGE and then transferred onto PDVF membranes by Western blotting.
The membranes were then probed using strepavidin-HRP and the labelled bands were visualised using autoradiography. The presence of a labelled 50 kDa protein
species corresponding in size to the F1 is shown. Also shown is a RIP assay from biotin-labelled mock-infected (M) cells. Plate H, a cross-section through a virus-
infected cell following LY294002-treatment is shown and the surface labelling by MAb19 is highlighted (white arrow).
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tinylation assay. In this assay, the surface-expressed F protein
was biotinylated, isolated by immunoprecipitation, and then
analysed by Western blotting as previously described (Sugrue et
al., 2001). Similar levels of the biotinylated F1 subunit were
detected in detergent-treated extracts prepared from non-treated
and drug-treated cells (Fig. 8, plate G), suggesting that similar
levels of surface-expressed F protein were present in each case.
Additionally, the presence of surface-expressed F protein on the
drug-treated cells can be seen when they are viewed in cross-
section (Fig. 8, plate H). In contrast, non-treated and LY294002-
treated cells labelled with anti-RSV showed inclusion bodies
which were similar in appearance, both in size and intensity of
labelling (Fig. 8, plates B and D). These data suggest that
although LY294002 appears to interfere with virus filament
formation, it does not inhibit either virus protein synthesis, or
the formation of other virus-induced structures such as inclusion
bodies. We noted that during a multiple cycle infection the
inclusion of LY294002 resulted in the absence of detectable
recoverable virus infectivity. It is not clear if this loss in virus
infectivity is a reflection on the loss of virus filaments, or somenon-specific effect that is due to prolonged exposure of the cells
to LY294002 (2–3 days) that can result in apoptosis in certain
cell types. However, our data suggests that PI3K activity may
play an important role during a specific phase of the virus
replication cycle, namely the formation of virus filaments.
During RSV infection PI3K activates the serine kinase Akt,
which in turn delays the onset of apoptosis during the latter
stages of virus infection (Thomas et al., 2002). However,
apoptosis is one of a variety of outcomes arising from the
activation of Akt, and Akt is only one of several downstream
effectors for PI3K (reviewed in Hawkins et al., 2006). Recent
evidence has demonstrated that actin rearrangements in the cell
can be mediated by a signalling pathway involving PI3K, Akt
and the Rac GTPase (Qian et al., 2005; Engelman et al., 2006).
In this pathway, the Rac GTPase-specific GEF is activated, and
the activated GEF then activates Rac GTPase. Therefore, in a
parallel experiment to that described above, we examined the
effect of the Rac-specific inhibitor NSC23766 (Gao et al., 2004)
on virus filament formation. NSC23766 inhibits activation of
Rac by preventing binding of the Rac-specific GEF and it has
been used to examine the role of Rac in several cellular
320 C.E. Jeffree et al. / Virology 369 (2007) 309–323processes (e.g. amyloid precursor protein processing, Desire et
al., 2005). RSV-infected cells were treated with 50 μg/ml
NSC23766 between 6 and 15 h pi, after which the cells were
fixed, labelled with either MAb19 (Fig. 8, plate E) or anti-RSV
(Fig. 8, plate F), and then examined by confocal microscopy.
NSC23766-treated cells showed a significant reduction in the
numbers of virus filaments, and the appearance of a punctate
labelling pattern (Fig. 8, plate E inset, highlighted by ⁎). This
pattern was similar to that observed on LY294002-treated cells.
In contrast, in cells labelled with anti-RSV (Fig. 8, plate F) the
inclusion bodies showed a similar appearance to that observed
in non-treated cells. These fluorescence microscopy observa-
tions suggest that activation of Rac GTPase by the PI3K
pathway may be an important step in the virus assembly
process. Since RhoA induces the activity of signalling pathways
that involve PI3K (reviewed in Hawkins et al., 2006; Engelman
et al., 2006), our observations are consistent with the in-
volvement of RhoA in virus filament formation that has been
previously reported (Gower et al., 2001, 2005).
The imaging techniques employed in this report have
provided ultrastructural evidence for a direct interaction
between F-actin and virus filaments. However, the formation
of newly polymerised actin during virus assembly appears not
to be required for this process. A direct interaction between F-
actin and virus filaments could therefore provide a mechanism
whereby host factors that are required for virus morphogenesis
can also be located to the sites of virus assembly. For example, it
has been established that actin is able to associate with the virus
polymerase complex, and this association appears to be
essential for polymerase activity (Barik, 1992; Huang et al.,
1993). Several reports have suggested that actin-associated cell
factors can interact with the polymerase complex in vitro
(Burke et al., 2000), although the significance of this interaction
is unclear (Bitko et al., 2003). However, these observations set a
precedent for the recruitment of actin, and actin-associated
proteins, to sites of virus activity within the cell.
Previous observations have suggested that structural changes
in the F-actin network are induced during RSV infection (Ulloa
et al., 1998; Burke et al., 1998). These changes appear to be
mediated by the activation of specific signalling pathways that
are associated with F-actin (Gower et al., 2005). Our data
suggest that an F-actin-associated signalling pathway which is
mediated by PI3K may play a role in the formation of the virus
filaments, although the precise mechanism involved is currently
unclear. PI3K signalling appears not to play a role in targeting
virus proteins, either to inclusion bodies or to the cell surface,
indicating that it is not directly involved in the recruitment of
virus proteins to the sites of virus assembly. However, virus
filament formation was largely ablated when PI3K, or its
downstream effector Rac GTPase, was inhibited. This suggests
that a signalling pathway involving these proteins may have a
role in the organisation of the virus proteins at the sites of virus
assembly, and in the subsequent formation of the virus filaments.
PI3K signalling plays a variety of regulatory roles in the cell,
including actin remodelling, and some of these functions could
be involved in the formation of virus filaments. For example,
profilin expression appears to play an important role during thefinal stages of virus maturation, since inhibiting profilin
expression prevents RSV morphogenesis, while virus replica-
tion is largely unaffected (Bitko et al., 2003). Several reports
have demonstrated an interaction between PI3K and profilin
(Singh et al., 1996; Lu et al., 1996; Bhargavi et al., 1998), which
can regulate the interaction between profilin and actin (Sathish et
al., 2004; Chen et al., 2004). Furthermore, there is an increasing
body of evidence that PI3K signalling pathways are associated
with lipid-raft membranes (Hope and Pike, 1996; Remacle-
Bonnet et al., 2005; Arcaro et al., 2007), which is consistent with
such signalling pathways playing a role in the formation of RSV
filaments in lipid-rafts (Brown et al., 2002a,b; McCurdy and
Graham, 2003). However, it remains to be established if the
interaction between RSV and specific host cell factors is
mediated via a PI3K-specific signalling pathway, and this
question will require further research.
In this study we examined the interaction between RSV and
HEp-2 cells during the process of virus maturation. The
formation of virus filaments and inclusion bodies is a common
feature of the virus replication cycle, being observed in a variety
of different cell types. Furthermore, these structures are also
observed in polarised cells in which membrane trafficking is
directional, where RSV preferentially assembles on the apical
membrane surface (Roberts et al., 1995). We have also observed
these structures in primary murine cells that have been directly
isolated from mouse lung (unpublished observations) suggest-
ing that they have physiological relevance. It is therefore likely
that some of the features described above (e.g. interaction with
actin) are likely to be a common facet of RSV infection and
independent of cell type. However, some features of these
different cell types may differ at the molecular level, which may
in turn lead to subtle differences in the way in which RSV
interacts with these different cell types at the cellular level, and
this will require further investigation.
Materials and methods
Cells and viruses
The RSV A2 strain was used throughout this study. HEp-2
cells were maintained in Dulbecco's Modified Eagle's Medium
(DMEM) supplemented with 10% foetal calf serum (FCS) and
antibiotics.
Antibodies and specific reagents
The RSV G (MAb30) and F (MAb19) protein antibodies
were provided by Geraldine Taylor, and the polyclonal antibody
anti-F was obtained from Jose Melero. The use of the M, N and
M2-1 protein antibodies have been described previously
(Henderson et al., 2002; Brown et al., 2005). Anti-RSV
(RCL3) was purchased from Novacastra Laboratories and
anti-actin from Sigma. Phalloidin-FITC was purchased from
Sigma Aldrich. Cytochalasin D (Sigma Aldrich) were prepared
in DMSO at 1 mg/ml and NSC23766 (Calbiochem) was
prepared in distilled water at 5 mg/ml. The inhibitors were
diluted into tissue culture media prior to use. Sulfo-NHS-LC-
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in PBS, pH 8.0 just prior to use.
Immunofluorescence
Cells on 13 mm glass coverslips were fixed with 4%
paraformaldehyde in PBS for 10 min at room temperature. The
cells were permeabilised with 0.1% Saponin/PBS and immu-
nolabelled, or stained with phalloidin-FITC as described pre-
viously (Brown et al., 2002b).
Surface protein biotinylation
This was performed using sulpho-NHS-LC-LC-biotin as
described previously (Sugrue et al., 2001).
The in situ preparation of cytoskeletons
In this analysis cells were grown on 20 mm2 silicon wafers
(TAAB) and infected with RSV at 33 °C and at 16 h pi
processed using the following methods. a) RSV-infected cells
were washed using PBS and then incubated for 20 min in 1%
Triton-X100 in PBS. The cells were monitored using light
microscopy during this time. The cells were then washed in PBS
and then treated for 60 min at 4 °C with 2.5% glutaraldehyde in
PBS. The cells were then washed in PBS and processed for
SEM (Jeffree et al., 2003). b) In an alternative method the
cytoskeleton preparation was based on that described pre-
viously (Schliwa et al., 1981). The cells were washed
extensively with PHEM buffer (60 mM Pipes, 25 mM Hepes,
10 mM EGTA, 2 mMgCl2, EDTA-free protease inhibitors
(Roche) pH 6.9). They were then incubated in PHEM buffer
containing 0.75% Triton-X100 and 5 μM phalloidin (Sigma-
Aldrich) for 2 min at room temperature. The cells were washed
with PHEM buffer and fixed with PHEM buffer containing 1%
glutaraldehyde (TAAB) for 10 min. After washing the cells for
2 min with distilled water containing 0.1 μM phalloidin, sodium
borohydride was added at 1 mg/ml for a further 2 min, after
which the cells were washed extensively with PBSA. The
samples were then processed for SEM.
Electron microscopy
Transmission Electron Microscopy (TEM)
Cells were prepared for TEM as described previously
(Brown et al., 2002a). a) Epon812 embedding. Cell mono-
layers were pelleted in BEEM capsules (TAAB) and fixed with
3% glutaraldehyde, 1% tannic acid, 100 mM sodium
cacodylate, pH 7.2. The cell pellet was then washed
extensively with 100 mM sodium cacodylate, pH7.2 and
post-fixed with 1% osmium tetroxide solution (TAAB). The
cell pellet was then dehydrated through a gradient of ethanol
concentrations and embedded in epon812 (TAAB). b) Unicryl
embedding. Cell monolayers were pelleted in BEEM capsules
and fixed for 5 h at 4 °C using 0·5% glutaraldehyde in PBS,
after which the fixed pellet was washed with PBS. The pellet
was dehydrated by transfer through a gradient of 30, 50, 70, 90and 100% ethanol. The cell pellet was subsequently infiltrated
with Unicryl (TAAB Laboratories) and the resin polymerized
by UV irradiation at −15 °C. Ultrathin sections were placed on
nickel-coated grids and incubated with the appropriate
monoclonal antibody (1/100 dilution) for 4 h at 25 °C. The
grids were washed with PBS and incubated for 4 h in anti-
mouse IgG (whole molecule) 10 nm colloidal gold conjugate
(Sigma). The samples were washed in PBS and fixed in
osmium tetroxide vapour for 2 h. The samples were then
stained using uranyl acetate (saturated in 50:50 ethanol/water),
washed in PBS and counter-stained with lead citrate.
Field emission scanning electron microscopy (FE SEM)
Cells were seeded on 20 mm2 silicon wafers (TAAB) and
were infected with RSV for 16 h at 33 °C. The cells were
washed with PBSA, after which they were fixed with 0.5%
glutaraldehyde in PBS at 4 °C for 30 min prior to washing
extensively with PBS. The specimens were labelled with
MAb30 and prepared for SEM as described previously (Jeffree
et al., 2003). The samples were sputtered with 2 nm chromium
in an EMITECH chromium sputter coater, and then viewed in a
Hitachi S4700FII field emission scanning electron microscope.
Digital images were recorded using Hitachi FE PCSEM (ver
3.2) software.
Radioimmunoprecipitation (RIP) analysis of [35S]methionine-
labelled virus
Sub-confluent T75 flasks containing HEp-2 cells were either
mock-infected or infected with RSVat a multiplicity of infection
of 0.1 and incubated at 33 °C. At 5 h pi the flasks were either
mock-treated or treated with cytochalasin D (5 μg/ml) and at 6 h
pi, the cells were washed with PBS and the incubation continued
in DMEM minus methionine containing 100 μCi/ml [35S]
methionine (Rediview™, Amersham), with or without cytocha-
lasin D as appropriate. The radiolabelled cell-free virus was
isolated, and analysed by RIP as previously described
(McDonald et al., 2006).
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